NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hanall Biopharma (KO: 009420)

 
009420 Technical Analysis
5
As on 27th Feb 2026 009420 STOCK Price closed @ 61700.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 32062.66 & Strong Buy for SHORT-TERM with Stoploss of 37925.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

009420STOCK Price

Open 62000.00 Change Price %
High 63800.00 1 Day 600.00 0.98
Low 61500.00 1 Week 7200.00 13.21
Close 61700.00 1 Month 12800.00 26.18
Volume 477324 1 Year 24350.00 65.19
52 Week High 62000.00 | 52 Week Low 24250.00
 
KO Korea Most Active Stocks
001510 2125.00 -1.16%
001510 2125.00 -1.16%
093230 33.00 -49.23%
093230 33.00 -49.23%
011930 2450.00 14.75%
011930 2450.00 14.75%
004060 685.00 3.32%
004060 685.00 3.32%
005930 216500.00 -0.69%
006340 6790.00 5.93%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
071670 10060.00 70.51%
071670 10060.00 70.51%
322000 104000.00 30.00%
322000 104000.00 30.00%
168490 159.00 29.27%
168490 159.00 29.27%
001020 849.00 25.22%
001020 849.00 25.22%
 
KO Korea Top Losers Stocks
001140 14.00 -83.53%
001140 14.00 -83.53%
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
 
 
009420
Daily Charts
009420
Intraday Charts
Whats New @
Bazaartrend
009420
Free Analysis
 
009420 Important Levels Intraday
RESISTANCE66132.10
RESISTANCE64710.70
RESISTANCE63832.10
RESISTANCE62953.50
SUPPORT60446.50
SUPPORT59567.90
SUPPORT58689.30
SUPPORT57267.90
 
009420 Forecast March 2026
4th UP Forecast82704.3
3rd UP Forecast75968.1
2nd UP Forecast71804.3
1st UP Forecast67640.5
1st DOWN Forecast55759.5
2nd DOWN Forecast51595.7
3rd DOWN Forecast47431.9
4th DOWN Forecast40695.7
 
009420 Weekly Forecast
4th UP Forecast73262.00
3rd UP Forecast69554.00
2nd UP Forecast67262.00
1st UP Forecast64970.00
1st DOWN Forecast58430.00
2nd DOWN Forecast56138.00
3rd DOWN Forecast53846.00
4th DOWN Forecast50138.00
 
009420 Forecast2026
4th UP Forecast138780
3rd UP Forecast114060
2nd UP Forecast98780
1st UP Forecast83500
1st DOWN Forecast39900
2nd DOWN Forecast24620
3rd DOWN Forecast9340
4th DOWN Forecast-15380
 
 
009420 Other Details
Segment EQ
Market Capital 1070211661824.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
009420 Address
009420
 
009420 Latest News
 
Your Comments and Response on Hanall Biopharma
 
009420 Business Profile
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea. Address: Daewoong Building, Seoul, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service